Search for: "ACTAVIS"
Results 621 - 640
of 1,006
Sorted by Relevance
|
Sort by Date
21 Sep 2014, 8:00 pm
Akamai Will Impact ANDA Litigation Involving Method of Treatment Patents FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis The Ever Shifting Boundaries of the Safe Harbor: Determining the Scope of 271(e)(1) Protections Relative to Paragraph IV Litigation After Classen and Momenta New Exclusivity Challenges for Brand Names and Generics: Exploring Their Implications for Paragraph IV Challenges The Uncertain… [read post]
7 Apr 2013, 7:26 pm
He described the circuit split leading to FTC v Actavis currently pending in the United States Supreme Court. [read post]
6 Apr 2015, 7:31 am
| Oprah Winfrey and OWN YOUR POWER trade mark | EPO December Administrative Council Meeting | Blurred Lines | Again on Actavis v Boehringer | Is the EU Patent Package diminishing the EU’s powers? [read post]
11 Dec 2018, 4:55 am
Rose writes that, in short, the Court dismissed Warner-Lambert's appeal that the patent was sufficiently disclosed, and upheld Actavis and Mylan's appeal that the disputed claims were not even partially sufficient. [read post]
7 Jan 2019, 9:19 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
13 Dec 2021, 12:49 am
The most recent decisions we have from the CJEU on Article 3(c) are Actavis I (C-443/12) and Actavis II (C-577/13) (IPKat). [read post]
26 Jan 2015, 4:03 am
.* No pain for Actavis: Warner-Lambert fail to stop launch of generic pregabalinSecond medical use claims, skinny labels, and public policy issues around healthcare are the topics addressed in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 72 (Pat) (21 January 2015), a decision that Mr Justice Arnold has just delivered and on which Darren timely comments in this post.* BREAKING NEWS: CJEU says exhaustion only applies to the tangible medium of… [read post]
8 Mar 2021, 1:17 am
This principle was considered by the UK Supreme Court in Warner Lambert v Actavis [2018] UKSC 56 (IPKat). [read post]
23 Feb 2015, 2:55 am
Never too late 32 [week ending Sunday 8 February] –- Brazilian PTO’s delays | The Research Handbook on International Intellectual Property reviewed | Laura Smith-Hewitt | IP, women and leadership: the poll responses | Decline of West’s trust in innovation | Wikipedia public domain photos |CJEU in Case C-383/12 P Environmental Manufacturing LLP v OHIM | The Nordic IP Forum | The future of EPO’s BoA | Warner-Lambert v… [read post]
20 Jul 2023, 3:44 am
BMS appealed the decision on several grounds (para. 89), mostly relating to whether the High Court had appropriately applied the law on plausibility as established by the UK Supreme Court in Warner-Lambert v Actavis [2018] UKSC 56. [read post]
22 Nov 2017, 3:14 am
Guest Kat Eibhlin answers the question by analyzing the recent decision Generics (U.K) v Yeda, a practical application of the Supreme Court’s Actavis v Eli Lilly.Internet and Digital Media Law conference returns to London! [read post]
16 Jan 2017, 11:21 am
") And an article titled "THE CIRCULAR LOGIC OF ACTAVIS " has: n129. [read post]
17 May 2018, 1:36 pm
Having presided over major decisions impacting both on IP law and practice, not the least Actavis v Eli Lilly, Baron Neuberger will be sharing his insights and reflections on “IP in the UK and Europe – a view from the top”. [read post]
28 Dec 2017, 2:44 am
Teva thereby faces the double whammy of not having a proprietary block-buster product to replace COPAXONE plus a declining competitive position in the generic market.Third, the company's declining fortunes in the generic drug area was exacerbated as a result of its acquisition in 2015 of the Actavis generic products division from Allergen. [read post]
4 Jan 2016, 7:28 am
**********PREVIOUSLY, ON NEVER TOO LATENever too late 78 [week ending on Sunday 27 December] – Zer-sum claim and lookalike products | 2015 Copyright Awards | Santa Claus and Section 52 | Jani writes on Dallas Buyers Club LLC v iiNet Limited | IP Hairballs | Actavis v Eli Lilly | Power outage at USPTO | Santa's GC resigns | Pet rock and IP.Never too late 77 [week ending on Sunday 20 December] – GC… [read post]
26 Jun 2015, 4:10 am
PatLit features a guest post from Richard Kempner, Brian Whitehead and Stuart Jackson on the brace of recent Court of Appeals patent decisions (ConvaTec and Actavis v Lilly) which are currently preoccupying those good souls who spend their lives seeking to extract meaning from patent claims and descriptions. [read post]
21 Mar 2015, 6:26 am
Actavis plc (NYSE:ACT), No. 1:14-cv-00882 (D. [read post]
10 Sep 2015, 5:47 pm
Flash forward one hundred or so years and look at the recent Pfizer case in England:From Bloomberg:Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug pregalbin.Pfizer… [read post]
11 Apr 2016, 2:38 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology. [read post]
18 May 2018, 5:25 am
The court then issued a permanentinjunction against Actavis’s manufacture, use, offer tosell, or sale of its generic version of OPANA®ER prior tothe expiration of the ’122 and ’216 patents. [read post]
